Vericel Corporation (VCEL)
NASDAQ · Healthcare
Vericel Corporation Shareholder Equity 2009–2025
Vericel Corporation annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vericel Corporation shareholder equity as of December 31, 2025: 354.6M, a 21.47% increase year-over-year.
- Vericel Corporation shareholder equity for 2025 were 354.6M, a 21.47% increase from 2024.
- Vericel Corporation shareholder equity for 2024 were 292.0M, a 29.22% increase from 2023.
- Vericel Corporation shareholder equity for 2023 were 226.0M, a 17.52% increase from 2022.
- Vericel Corporation shareholder equity for 2022 were 192.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vericel Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $355 |
| 2024 | $292 |
| 2023 | $226 |
| 2022 | $192 |
| 2021 | $170 |
| 2020 | $134 |
| 2019 | $111 |
| 2018 | $102 |
| 2017 | $23 |
| 2016 | $25 |
| 2015 | $22 |
| 2014 | $36 |
| 2013 | $4 |
| 2012 | $-32 |
| 2011 | $-13 |
Vericel Corporation Shareholder Equity — FAQ
Vericel Corporation (VCEL) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VCEL's shareholder equity history?
The chart and table above show Vericel Corporation's shareholder equity by year and by quarter, including the growth rate.